IL2 and autoimmune disease: Treg essentially depend on IL-2 for their peripheral maintenance and suppressive activity (103, 104) and their number and activity can be therapeutically manipulated by low-dose IL-2 and particular IL-2/anti-IL-2 complexes (105, 106) to control autoimmune diseases and inflammation (107).